Delivery Order SPE2DB22D1202-SPE2DB25FVCN3
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 26, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $7,025.59. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 29, 2025. The contract represents a child delivery order under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Otezla 30 mg tablets in a quantity of 60 units, with a contract ceiling value of $7,352.82. This award represents a firm fixed price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,324.90. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. The award was not designated as a set-aside contract and was competitively awarded. Performance of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $2,692.18. This firm fixed-price delivery order, which will be completed by January 2, 2026, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 13, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $60,644.38. The contract carries a firm fixed price structure with an ultimate completion date of August 14, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...
- Amerisourcebergen Drug Corp (now operating under parent company Cencora, Inc.) was awarded a delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Otezla 30 mg tablets (60-count packages) with a ceiling value of $1,978.47. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026, and represents a non-set-aside, competitively awarded procurement. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $9,461.61. This firm fixed-price delivery order, which is not set-aside, is expected to be completed by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $11,352.47 from the Defense Logistics Agency (DLA) on January 16, 2026, for the supply of Otezla 30 mg tablets (60-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Otezla 30 mg tablets (60-count units) valued at $34,867.15. The contract, which is not designated as a set-aside, carries a firm fixed price structure with an ultimate completion date of August 20, 2025. This delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...